ArticleExperimental and therapeutic medicine2021

Saxagliptin protects against diabetic nephropathy by inhibiting caspase 3/PARP-1-dependent nephrocyte apoptosis.

Xiaowei Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.